search

Active clinical trials for "Dry Eye Syndromes"

Results 611-620 of 976

Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease...

Dry Eye

This study evaluates the use of Brimonidine tartrate nanoemulsion eye drop solution in the treatment of Dry Eye Disease (DED). Half of participants will receive Brimonidine and half will receive ophthalmic buffered saline (placebo).

Completed26 enrollment criteria

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Dry Eye Disease

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

Completed2 enrollment criteria

Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline

Dry Eye Syndrome

The purpose of this study is to evaluate the ocular retention time of Systane Ultra compared to Hialid and saline.

Completed11 enrollment criteria

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With...

Contact Lens Dry Eye

The primary objective of this study is to compare the duration of subject reported comfortable contact lens daily wear time in subjects with a history and current complaint of CLDE during a 29-day treatment period of azithromycin ophthalmic solution, 1%, compared to rewetting drops

Completed10 enrollment criteria

An Evaluation of the Daytime Use of an Investigational Lubricant Eye Drop

Dry Eye

The purpose of this study is to describe the subjective assessments of an investigational lubricant eye drop.

Completed4 enrollment criteria

Partial Lacrimal Punctual Occlusion

Dry Eye

The purpose of this study is to describe a case series of patients with chronic dry eye submitted to partial punctual occlusion.

Completed4 enrollment criteria

Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

Dry Eye DiseaseOcular Comfort

To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with cyclosporine ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of treatment for chronic dry eye disease

Completed11 enrollment criteria

Acute Comfort and Blur of Systane and Optive

Dry Eye

To evaluate drop comfort, acceptability, preference and blur profile between two marketed artificial tears in both dry eye and non-dry eye patient population.

Completed2 enrollment criteria

Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

Dry Eye

This was a single-center, randomized, double-masked, placebo-controlled, parallel-group, 4-visit, CAE (Controlled Adverse Environment) study lasting approximately 4 weeks. Subjects were randomized to receive loteprednol etabonate ophthalmic suspension, 0.5% or placebo (vehicle of loteprednol etabonate ophthalmic suspension, 0.5%) and instructed to dose bilaterally either TID or QID according to randomization.

Completed18 enrollment criteria

Acute Comfort of Lubricant Eye Drop FID 111421

Dry Eye

To evaluate the acute comfort and blurring profile between two artificial tears products in dry eye patients

Completed3 enrollment criteria
1...616263...98

Need Help? Contact our team!


We'll reach out to this number within 24 hrs